HOME Press Releases Wound Care Market worth 22.01 Billion USD by 2022



Wound Care Market worth 22.01 Billion USD by 2022


The report "Wound Care Market by Product (Advanced (Foam, Alginate, Hydrogel, NPWT, Active), Surgical, Traditional), Type (Chronic (Diabetic Foot, Pressure Ulcer), Acute (Burn, Trauma)), End User (Hospital, Long-term Care, Home Healthcare) - Global Forecast to 2022", The wound care market is expected to reach USD 22.01 Billion by 2022 from USD 18.35 Billion in 2017, at a CAGR of 3.7%. Factors driving the growth of this market include the increasing prevalence of chronic wounds and acute wounds, increasing aged population, rising R&D activities and advancement in the field of wound care research, rising number of road traffic accidents globally, and the increasing awareness about wound care treatment and management through awareness programs.

                              Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 356 Market Data Tables and 50 Figures spread through 319 Pages and in-depth TOC on "Wound Care Market by Product (Advanced (Foam, Alginate, Hydrogel, NPWT, Active), Surgical, Traditional), Type (Chronic (Diabetic Foot, Pressure Ulcer), Acute (Burn, Trauma)), End User (Hospital, Long-term Care, Home Healthcare) - Global Forecast to 2022"
http://www.marketsandmarkets.com/Market-Reports/wound-care-market-371.html
Early buyers will receive 10% customization on reports.

Advanced wound management products are estimated to account for the largest market share in 2017

On the basis of product type, the wound care market is classified into advanced wound management products, surgical wound care products, and traditional wound care products. Advanced wound management products are expected to lead the global wound care market in 2017. Factors driving the growth of this segment include the increasing incidence of diabetes and the rising demand for innovative and advanced wound management products.

The chronic wounds segment is estimated to dominate the market in 2017

By the type of wound, the market is bifurcated into chronic wounds and acute wounds. The chronic wounds segment is anticipated to account for the largest share of the global wound care market. Factors such as the increasing geriatric population and the rising incidence of diabetic foot ulcers, pressure ulcers, and other types of chronic wounds, are driving the growth of this market.

By end user, hospitals and specialty wound care clinics are estimated to command for the largest share of the market during the forecast period

On the basis of end users, the wound care market is categorized into hospitals and specialty wound care clinics, long-term care facilities, and home healthcare. The hospitals and specialty wound care clinics segment is estimated to account for the largest share of the global wound care market. Increasing patient admissions for the treatment of chronic wounds, rising incidence of diabetes, and improving hospital infrastructure in developing countries are key factors driving the growth of this end-user segment.

North America is estimated to command the largest share of the market

Based on region, the wound care market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is expected to dominate the wound care market in 2017, this is attributed to factors like increasing research activities in the field of wound care and rising governmental investment for wound care research in the region as compared to other regions.

Key players in the wound care market include Acelity L.P. Inc. (US), Smith & Nephew plc  (UK), Mölnlycke Health Care AB (Sweden), ConvaTec Group Plc (UK), Baxter International Inc. (US), Coloplast A/S (Denmark), BSN medical GmbH (Germany), Organogenesis Inc. (US), DeRoyal Industries, Inc.(US), IonMed (Israel), Ethicon, Inc. (US), Medtronic plc (Ireland), 3M Company (US), Hill-Rom Holdings, Inc. (US), Paul Hartmann AG (Germany), NovaBay Pharmaceuticals, Inc. (US),  Derma Sciences, Inc. (US), Vivostat A/S (Denmark), Wound Care Technologies, Inc. (US), Leap Therapeutics Inc. (US),  Hematris Wound Care GmbH (Germany), Alliqua BioMedical, Inc. (US), LayerBio Inc. (US) Triage Meditech Pvt. Ltd (India), and Fidia Pharma USA Inc. (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports